Innovation
SynthesEyes enables virtual simulations and synthetic data generation of ophthalmic surgery based on digital twins of real patient data. This enhances surgical education by combining real patient anatomy with virtual and physical environments, providing a more immersive and effective learning experience. Accelerating skill acquisition is essential, yet mentorship opportunities remain limited and costly. By improving accessibility, efficiency, and standardization, SynthesEyes aim to improve the currently high dissatisfaction among over 40% of ophthalmology trainees and ensures broader access to high-quality surgical training, enabling trainees to develop expertise faster while optimizing mentorship resources and advancing global surgical education. In addition, the SynthesEyes simulation system allows medical device companies to accelerate their product development by providing a virtual prototyping platform and generating synthetic data for development and testing.
Teamvorstellung
Michael Sommersperger has over 6 years of experience in ophthalmic research with a background of a PhD, specializing in medical visualization and AI in ophthalmic surgery.
Shervin Dehghani has a background of a PhD in AI and robotics. His expertise in computer vision and machine learning enhances the development of user interaction systems and future directions in ophthalmology.
Both, Michael and Shervin gained experience from years of collaborations with Johns Hopkins University and Carl Zeiss Meditec.
Mathias Großschädl focuses on strategic development and oversight of business processes. After studying economics and business, his experience in financial management, personnel planning, and investment strategy supports SynthesEyes.
The project benefits from the technical and organizational guidance by Prof. Dr. Nassir Navab and Prof. Dr. Ali Nasseri at TU Munich, with clinical insights from Dr. Koorosh Faridpooya as Senior Vitroretinal Surgeon at Rotterdam Eye Hospital.
Kooperationspartner
SynthesEyes has been validated in scientific studies to generate synthetic data and assess surgical performance. Collaborations with the Klinik und Poliklinik für Augenheilkunde at the Klinikum Rechts der Isar (MRI) and Ludwig-Maximilians-Universität München (LMU) enable real-world validation, refining training for ophthalmic surgeons. At MRI, SynthesEyes has supported studies evaluating surgeon performance in simulated environments, providing insights not possible in live surgeries. Partnering with Rotterdam Eye Hospital (REH), remote training courses are planned under the supervision of expert vitreoretinal surgeons like Dr. Koorosh Faridpooya. This ensures real-time feedback, enhancing ophthalmic education, optimizing mentorship, and improving accessibility to high-quality surgical training.
Marktpotenzial/ Geschäftsmodell
The healthcare digital twin market, valued at $1.57 billion in 2023, is projected to grow at a 45% CAGR, reaching $36.46 billion by 2031. SynthesEyes taps into this rapidly expanding market with an innovative ophthalmic surgery training system, combining patient-specific digital twins with real surgical instruments to create realistic, customizable training environments. The company follows a hybrid pricing model, offering a one-time payment for hardware and software licenses, ensuring a low financial entry barrier. Additional revenue comes from generating synthetic data for medical device companies and after-sales services, ensuring steady cash flow. After system development and validation, real-world testing will be conducted. Following the pilot phase, the product will first launch in Germany, with plans for expansion into European and global markets, where there is a high demand for medical education.